Question 1

Does Jacobs Levy Equity Management own DSGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Jacobs Levy Equity Management holds 565,597 shares of DSGN (Design Therapeutics), worth $8.2M.

Question 2

How many shares of DSGN does Jacobs Levy Equity Management own?

Accepted Answer

As of its Q2 2026 13F, Jacobs Levy Equity Management holds 565,597 shares of DSGN (Design Therapeutics).

Question 3

What is Jacobs Levy Equity Management's DSGN position worth?

Accepted Answer

As of its Q2 2026 13F, Jacobs Levy Equity Management's DSGN position is worth $8.2M.

Question 4

Is Jacobs Levy Equity Management buying or selling DSGN?

Accepted Answer

In Q2 2026, Jacobs Levy Equity Management increased its DSGN position by 276,212 shares (+95.5%).

Question 5

When did Jacobs Levy Equity Management first buy DSGN?

Accepted Answer

Jacobs Levy Equity Management first reported DSGN in its Q2 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	565,597	+95.5%	$8.2M	0.0%	$14.47	44
2026-Q1	Increased	289,385	+48.7%	$3.1M	0.0%	$10.00	36
2025-Q4	New	194,611	-	$1.8M	0.0%	$9.79	36
2025-Q3	Exited	0	-100.0%	$0	0.0%	$6.85	0
2025-Q2	Decreased	13,501	-22.8%	$45,498	0.0%	$3.57	0
2025-Q1	Decreased	17,482	-4.3%	$67,481	0.0%	$4.21	0
2024-Q4	Decreased	18,261	-93.5%	$112,670	0.0%	$6.17	0
2024-Q3	Decreased	280,271	-41.1%	$1.5M	0.0%	$5.33	0

DSGNShowing 8 of 13 quarters

DSGN
Showing 8 of 13 quarters